aTyr Pharma | LIFE - Trade Creditors

Stock Price
0.50
Daily Change
-0.06 -9.98%
Monthly
-39.31%
Yearly
-84.59%
Q2 Forecast
0.49

aTyr Pharma reported $2.76M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Ardelyx USD 28.2M 8.96M Mar/2026
aTyr Pharma USD 2.76M 52.32M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Curis USD 5.61M 1.52M Dec/2025
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Grifols EUR 987.75M 47.87M Dec/2025
Lakefront Biotherapeutics EUR 95.77M 8.88M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
United Therapeutics USD 498.3M 491.2M Mar/2026
Xoma USD 2.65M 1.52M Sep/2025